Haematology Flashcards
Bleeding diathesis history questions
(Then a focus on nose bleeds)
- Family history of bleeding disorders
- Previous surgical procedures incl tooth extractions - with significant bleeding
- Previous abnormal bleeding: gums, nose, haematuria, malena
- Constitutional symptoms
- Menstrual history
- Alcohol history
- Intranasal steroids/sprays
- Nose picking
- Cocaine use
- Domestic violence
Bleeding diatheses examination findings
- Shock/hypovolaemia signs
- Hepatomegaly/ splenomegaly
- Lymphadenopathy
- Signs of anaemia- conjunctival pallor
- Petechiae/ecchymoses
- Stigmata of liver disease- scleral icterus, spider naevi
- Telangiectasia
Causes of polycythemia
- Dehydration (relative)
Primary
- Polycythaemia vera
- EPO receptor mutation
Secondary (elevated EPO)
a) hypoxia
- Lung dx
- OSA
- R-L shunt
- Altitude
b) EPO
- EPO tumor: RCC, HCC
- Androgen use
Investigations for polycythaemia
- FBC, EUC, LFT
- Iron studies
- 02 sats
- EPO level
Consider:
- Genetics: Jak2, BCR-ABL1 (Philadelphia cr)
- Sleep study
- US/CT abdo (Epo tumor)
- ECHO
- CXR
Four classic Myeloproliferative neoplasms:
- Polycythemia vera
- Essential thrombocytosis
- PMF
- CML
Platelet level cut off for thrombocytopenia
<150
Work up for asymptomatic thrombocytopenia
FBC and film
Platelets
fibrinogen, D-dimer, clotting factors
Haemolysis screen
B12, folate
LFTs
HIV & hepatitis serology
FOBT
EUCs
Platelet level when to refer
50-100 non urgent referral
Consider early referral >60yo
When to administer Vitamin K for supratherapeutic INR
4.5-10
Also HIGH risk for bleeding
** high risk =
Major bleed in last 4 weeks, major surgery in last 2 weeks, platelets <50, Liver disease or on antiplatelet therapy
Investigations for neutropenia
- Repeat FBC in 8 weeks
- B12, folate ,copper levels
- LFTs, HIV, HBV, HCV, EBV, CMV
- Coags ,LDH (for febrile or unstable patient)
Investigations for persistent polycycthaemia
- Pulse ox
- LFTs, EUC, Creatinine, BGL
- EPO
- Urinalysis
Haemachromatosis: p.Cys282Tyr (aka C282Y) homozygote
At risk of iron overload?
At what rates ?
Should you screen relatives
Yes
Male: 75-100%
Female 40-60%
YES - screen >18yrs
Haemachromatosis: p.Cys282Tyr /p.His63Asp
(aka C282Y/H63D)
Compound heterozygote
At risk of iron overload? At what rates ?
Recommended time frame for iron studies
Yes 1%
Every 2-5 yrs
Should
Haemachromatosis:
C282Y or H63D Heterozygote
OR
p.His63Asp (H63D) Homozygote
At risk of iron overload?
NO increased risk
Time frame for anticoagulation post PROVOKED VTE
6 weeks